| Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study E Martinez, A Mocroft, MA García-Viejo, JB Pérez-Cuevas, JL Blanco, ... The Lancet 357 (9256), 592-598, 2001 | 567 | 2001 |
| COVID-19 in patients with HIV: clinical case series JL Blanco, J Ambrosioni, F Garcia, E Martínez, A Soriano, J Mallolas, ... The lancet HIV 7 (5), e314-e316, 2020 | 534 | 2020 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients M Laguno, J Murillas, JL Blanco, E Martínez, R Miquel, ... Aids 18 (13), 27-36, 2004 | 524 | 2004 |
| Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy E Martínez, JL Blanco, JA Arnaiz, JB Pérez-Cuevas, A Mocroft, A Cruceta, ... Aids 15 (10), 1261-1268, 2001 | 470 | 2001 |
| Pitavastatin to prevent cardiovascular disease in HIV infection SK Grinspoon, KV Fitch, MV Zanni, CJ Fichtenbaum, T Umbleja, JA Aberg, ... New England Journal of Medicine 389 (8), 687-699, 2023 | 449 | 2023 |
| Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study J Del Amo, R Polo, S Moreno, A Díaz, E Martínez, JR Arribas, I Jarrín, ... Annals of internal medicine 173 (7), 536-541, 2020 | 435 | 2020 |
| Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine E Martínez, I Conget, L Lozano, R Casamitjana, JM Gatell Aids 13 (7), 805-810, 1999 | 417 | 1999 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrin, J Carratala, J Pachon, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 409 | 2020 |
| Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection E Martínez, JA Arnaiz, D Podzamczer, D Dalmau, E Ribera, P Domingo, ... New England Journal of Medicine 349 (11), 1036-1046, 2003 | 395 | 2003 |
| Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count F García, E de Lazzari, M Plana, P Castro, G Mestre, M Nomdedeu, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 36 (2), 702-713, 2004 | 288 | 2004 |
| European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV* JD Lundgren, M Battegay, G Behrens, S De Wit, G Guaraldi, C Katlama, ... HIV medicine 9 (2), 72-81, 2008 | 280 | 2008 |
| Continuous antiretroviral therapy decreases bone mineral density B Grund, G Peng, CL Gibert, JF Hoy, RL Isaksson, JC Shlay, E Martinez, ... Aids 23 (12), 1519-1529, 2009 | 274 | 2009 |
| Severe nucleoside-associated lactic acidosis in human immunodeficiency virus–infected patients: report of 12 cases and review of the literature V Falcó, D Rodríguez, E Ribera, E Martínez, JM Miró, P Domingo, ... Clinical infectious diseases 34 (6), 838-846, 2002 | 260 | 2002 |
| Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy A Suy, E Martínez, O Coll, M Lonca, M Palacio, E de Lazzari, M Larrousse, ... Aids 20 (1), 59-66, 2006 | 253 | 2006 |
| Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study E Martinez, M Larrousse, JM Llibre, F Gutierrez, M Saumoy, A Antela, ... Aids 24 (11), 1697-1707, 2010 | 249 | 2010 |
| Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults MA Marcos, MTJ de Anta, JP de la Bellacasa, J González, E Martinez, ... European Respiratory Journal 21 (2), 209-214, 2003 | 249 | 2003 |
| Overview of SARS-CoV-2 infection in adults living with HIV J Ambrosioni, JL Blanco, JM Reyes-Urueña, MA Davies, O Sued, ... The lancet HIV 8 (5), e294-e305, 2021 | 221 | 2021 |
| The role of viruses in the aetiology of community-acquired pneumonia in adults MA Marcos, M Camps, T Pumarola, JA Martinez, E Martinez, J Mensa, ... Antiviral therapy 11 (3), 351-359, 2006 | 221 | 2006 |
| Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy E Martínez, MA García-Viejo, JL Blanco, L Bianchi, E Buira, I Conget, ... Clinical infectious diseases 31 (5), 1266-1273, 2000 | 193 | 2000 |
| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ... HIV medicine 21 (10), 617-624, 2020 | 189 | 2020 |
